Bin Xu | OMICS International

Journal of Cellular and Molecular Pharmacology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Bin Xu

Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, PR China


He is affiliated to Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, PR China. He is a recipient of many awards and grants for his valuable contributions and discoveries in major area of subject research. His international experience includes various programs, contributions and participation in different countries for diverse fields of study.  His research interests reflect in his wide range of publications in various national and international journals. 



Antimetastatic Mechanisms of Bisdioxopiperazine Compound Study, A Gateway to Success

Neoplasm metastasis is the causality of 90% cancer patient’s mortality. Bisdioxopiperazine compounds (Biz compounds) are a series of synthetic agents that are firstly discovered to exhibit antimetastatic efficacy to animal tumor models. In order to completely overcome neoplasm metastasis in clinics, antimetastatic therapeutic study for Biz co... Read More»

Da-Yong Lu, Jian Ding, Rui-Ting Chen, Bin Xu, Nagendra Sastry Yarla and Ting-Ren Lu

Editorial: J Cell Mol Pharmacol

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article